Mid-Cap Pharma Stock: Indian Arm of Covid Vaccine Maker Soars 8 per cent Mid-Cap Pharma Stock: Indian Arm of Covid Vaccine Maker Soars 8 per cent Company's Board Approves Marketing and Supply Agreement with Mylan Pharmaceuticals Abhishek Wani / Monday, February 24, 2025 0 95 Article rating: 5.0 Company's Board Approves Marketing and Supply Agreement with Mylan Pharmaceuticals Read more